These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15300675)

  • 81. Therapeutic use of medical Cannabis in neurological diseases: a clinical update.
    Hidding U; Mainka T; Buhmann C
    J Neural Transm (Vienna); 2024 Feb; 131(2):117-126. PubMed ID: 38015317
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cannabinoids and dystonia: an issue yet to be defined.
    Mascia MM; Carmagnini D; Defazio G
    Neurol Sci; 2020 Apr; 41(4):783-787. PubMed ID: 31848779
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Consensus paper: Decoding the Contributions of the Cerebellum as a Time Machine. From Neurons to Clinical Applications.
    Bareš M; Apps R; Avanzino L; Breska A; D'Angelo E; Filip P; Gerwig M; Ivry RB; Lawrenson CL; Louis ED; Lusk NA; Manto M; Meck WH; Mitoma H; Petter EA
    Cerebellum; 2019 Apr; 18(2):266-286. PubMed ID: 30259343
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Association between gene polymorphisms and obesity and physical fitness in Korean children.
    Kim HJ; Lee SY; Kim CM
    Biol Sport; 2018 Mar; 35(1):21-27. PubMed ID: 30237658
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3.
    Rodríguez-Cueto C; Hernández-Gálvez M; Hillard CJ; Maciel P; Valdeolivas S; Ramos JA; Gómez-Ruiz M; Fernández-Ruiz J
    PLoS One; 2017; 12(4):e0176521. PubMed ID: 28448548
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Time Processing and Motor Control in Movement Disorders.
    Avanzino L; Pelosin E; Vicario CM; Lagravinese G; Abbruzzese G; Martino D
    Front Hum Neurosci; 2016; 10():631. PubMed ID: 28018198
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Strategies for treatment of dystonia.
    Dressler D; Altenmueller E; Bhidayasiri R; Bohlega S; Chana P; Chung TM; Frucht S; Garcia-Ruiz PJ; Kaelin A; Kaji R; Kanovsky P; Laskawi R; Micheli F; Orlova O; Relja M; Rosales R; Slawek J; Timerbaeva S; Warner TT; Saberi FA
    J Neural Transm (Vienna); 2016 Mar; 123(3):251-8. PubMed ID: 26370676
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia.
    García C; Palomo-Garo C; Gómez-Gálvez Y; Fernández-Ruiz J
    Br J Pharmacol; 2016 Jul; 173(13):2069-79. PubMed ID: 26059564
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Focal Task-specific Dystonia-From Early Descriptions to a New, Modern Formulation.
    Frucht SJ
    Tremor Other Hyperkinet Mov (N Y); 2014; 4():230. PubMed ID: 24757587
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Rating scales for musician's dystonia: the state of the art.
    Peterson DA; Berque P; Jabusch HC; Altenmüller E; Frucht SJ
    Neurology; 2013 Aug; 81(6):589-98. PubMed ID: 23884039
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders.
    Fernández-Ruiz J; Hernández M; Ramos JA
    CNS Neurosci Ther; 2010 Jun; 16(3):e72-91. PubMed ID: 20406253
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cannabinoids in health and disease.
    Kogan NM; Mechoulam R
    Dialogues Clin Neurosci; 2007; 9(4):413-30. PubMed ID: 18286801
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The endocannabinoid system as an emerging target of pharmacotherapy.
    Pacher P; Bátkai S; Kunos G
    Pharmacol Rev; 2006 Sep; 58(3):389-462. PubMed ID: 16968947
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [The endogenous cannabinoid system. Therapeutic implications for neurologic and psychiatric disorders].
    Schneider U; Seifert J; Karst M; Schlimme J; Cimander K; Müller-Vahl KR
    Nervenarzt; 2005 Sep; 76(9):1062, 1065-6, 1068-72 passim. PubMed ID: 15776259
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Musician's dystonia.
    Pullman SL; Hristova AH
    Neurology; 2005 Jan; 64(2):186-7. PubMed ID: 15668411
    [No Abstract]   [Full Text] [Related]  

  • 96. Bach, botox, and butterflies: toward an awareness of musician's dystonia.
    Passero MA
    Med Health R I; 2007 Aug; 90(8):238-9. PubMed ID: 17867407
    [No Abstract]   [Full Text] [Related]  

  • 97. Failure of cathodal direct current stimulation to improve fine motor control in musician's dystonia.
    Buttkus F; Weidenmüller M; Schneider S; Jabusch HC; Nitsche MA; Paulus W; Altenmüller E
    Mov Disord; 2010 Feb; 25(3):389-94. PubMed ID: 20063390
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Focal hand dystonia in musicians: phenomenology, etiology, and psychological trigger factors.
    Altenmüller E; Jabusch HC
    J Hand Ther; 2009; 22(2):144-54; quiz 155. PubMed ID: 19278826
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Delta9-tetrahydrocannabinol improves motor control in a patient with musician's dystonia.
    Jabusch HC; Schneider U; Altenmüller E
    Mov Disord; 2004 Aug; 19(8):990-1. PubMed ID: 15300675
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.